Predicting pN positivity in T3 rectal cancer
Authors:
T. Dušek 1,2; A. Ferko 1; J. Örhalmi 1; M. Chobola 1; O. Sotona 1; D. Hadži Nikolov 3; E. Hovorková 3
Authors place of work:
Chirurgická klinika Fakultní nemocnice Hradec Králové a Lékařské Fakulty UK v Hradci Králové
přednosta kliniky: prof. MUDr. A. Ferko, CSc.
1; Katedra vojenské chirurgie, Fakulta vojenského zdravotnictví, Hradec Králové, Univerzita obrany, Brno
vedoucí: doc. MUDr. J. Páral, Ph. D.
2; Fingerlandův ústav patologie Fakultní nemocnice Hradec Králové a Lékařské Fakulty UK v Hradci Králové
přednosta ústavu: prof. MUDr. A. Ryška, Ph. D.
3
Published in the journal:
Rozhl. Chir., 2014, roč. 93, č. 12, s. 572-576.
Category:
Original articles
Podpořeno MZ ČR – RVO (FNHK, 00179906)
Summary
Introduction:
Stage pN+ is a factor which determines the strategy for treatment of T3 rectal cancer. The sensitivity of preoperative imaging examinations revealing N+ is not entirely satisfactory. Risk factors that are associated with pT3pN+ stage and that are detectable by preoperative examination have not been reliably identified. The aim of the study is to analyze the predictive factors determining lymph node involvement in T3 rectal cancer.
Material and methods:
Patients with rectal resection for (y)pT3 rectal cancer were analysed. All of the surgical interventions were performed at the Department of Surgery, University Hospital in Hradec Kralove, from 1 January 2011 to 28 February 2014. Data were prospectively collected and saved in the Rectal Cancer Oncologic Register. The parameters studied were age, gender, tumour localisation and its circumferential topography, preoperative chemoradiotherapy, absolute number of harvested lymph nodes and the number of positive lymph nodes in each specimen, tumour grading, presence of lymphovascular invasion and perineural invasion, and the depth of tumour penetration.
Results:
After selection, 89 patients with T3 rectal cancer were included into the study. Resection for cancer of the upper rectum was performed in 22 (24.7%) patients, middle rectum in 37 (41.6 %) and lower rectum in 30 (33.7%) patients. 38 (42.7%) patients underwent primary operation, 41 (46.1%) patients received neoadjuvant chemoradiotherapy, and radiation therapy was administered to only 10 (11.2%) patients. Stage pN+ was found in 51 (57.3%) patients. Statistical analysis was used to identify the risk factors for pN+: lymphovascular invasion (p≤0.001), angioinvasion (p=0.030) and perineural invasion (p=0.010). On the border of statistical significance for pN+, low grading of the tumour (p=0.084) was found. The depth of penetration of the tumour into the mesorectum was not statistically significant (p=0.230).
Conclusion:
Our study has shown that pN positivity is associated with lymphovascular invasion, perineural invasion and low grading of the tumour. Accurate identification of these factors before treatment, however, remains very difficult.
Key words:
T3 rectal cancer − mesorectal extension depth − lymphovascular invasion − perineural invasion − lymph node involvement
Zdroje
1. Shin JY, Kwan HH. Prognostic significance of lymph node ratio in stage III rectal cancer. J Korean Soc Coloproctol 2011;27:252−9.
2. Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JCh, et al. Diagnostic accuracy of MRI for assesment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review an meta-analysis. Ann Surg Oncol 2012;19:2212−23.
3. Zhou J, Songhua Z, Qiong Z, Hangjhun G, Yidong W, et la. Prediction of nodal involvement in primary rectal carcinoma without invasion to pelvic structures: accuracy of preoperative CT, MR, and DWIBS assessments. PloS One 2014;4,published online.
4. Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, et al. The prognostic inhomogenity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16:298−304.
5. Fucini C, Pucciani F, Elbetti C, Gattai R, Russo A. Preoperative radiochemotherapy in T3 operable low rectal cancers: A gold standard? World J Surg 2010;34:1609−14.
6. Yimei J, Ren Z, Lu X, Huan Z. A comparison between the reference values of MRI and EUS and their usefulness to surgeons in rectal cancer. Eur Rev Med Pharmacol Sci 2012;16:2069−77.
7. Ren JH, Guo FJ, Dai WD, Han XJ, Ma N. Study of endorectal ultrasonography in the staging of rectal cancer. Chin Med J (Engl) 2012;125:3740−43.
8. Baek SJ, Kim SH, Kwak JM, Cho JS, Shin JW, et al. Selective use of preoperative chemoradiotherapy for T3 rectal cancer can be justified: Analysis of local reccurence. World J Surg 2013;37:220−6.
9. Shin R, Jeong SY, Yoo HY, Park KJ, Heo SCh, et al. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum 2012;55:1220−28.
10. Guillem JG, Díaz-González JA, Minsky BD, Valentini V, Jeong SY, et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncolog. 2008;20:368−73 .
11. Augestad KM, Lindsetmo RO, Stulberg J, Reynolds H, Senagore A, et al. International rectal cancer Study Group (IRCSG). International preoperative rectal cancer management staging, neodjuvant treatment and impact of multidisciplinary teams. World J Surg 2010;34:2689−700.
12. Peng J, Sheng W, Huang D, Venook AP, Xu Y, et al. Perineural invasion in pT3N0 rectal cancer. The incidence and its prognostic Effect. Cancer 2011;117:1415−21.
13. Picon AI, Moore HG, Sternberg SS, Minksy BD, Paty PB, et al. Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3N0M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis 2003;18:487−92.
14. Nissan A, Stojadinovic A, Shia J, Hoos A, Guillem JG, et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol 2006;24:4078−84.
15. Frasson M, Garcia-Granero E, Roda D, Flor-Lorente B, Roselló S, et al. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer 2011;117:3118−25.
16. Glasgow SC, Bleier JIS, Burgart LJ, Finne ChO, Lowry AC. Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointestinal Surg 2012;16:1019−28.
17. Carrara A, Mangiola D, Pertile R, Ricci A, Motter M, et al. Analysis of risk factors for lymph nodal involvement in early stages of rectal cancer: when can local excision be considered an appropriate treatment? Systematic review and meta-analysis of the literature. Int J Surg Oncol 2012;published online.
18. Saraste D, Gunnarsson U, Janson M. Predicting lymph node metastases in early rectal cancer. Eur J Cancer 2013;49:1104−08.
19. Huh JW, Kim HR, Kim YJ. Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 2010;14:1074−80.
20. Jong HL, Hong SJ, Jun-Gi K, Hyun MCh, Byoung YS, et al. Lymphovascular invasion is a prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Ann Surg Oncol 2012;19:1213−21.
21. Peschl EM, Pollheimer MJ, Kornprat P. Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J Clin Oncol 2010;28:358−60.
22. Pollhemimer M, Kornprat P, Pollheimer VS, Lindtner RA, Schlemmer A, et al. Clinical significance of pT subclassification in surgical pathology of colorectal cancer. Int J Colorectal Dis 2010,25:187−96.
23. Miyoshi M, Ueno H, Hashiguchi Y, Mochizuki H, Talbot IC. Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 2006;243:492−8.
24. Brandt WS, Yong S, Abood G, Micetich K, Walther A, et al. The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection. Am J Surg 2014;207:357−60.
25. Kajiwara Y, Ueno H, Hashiguchi Y, Mocjizuki H, Hase K. Risk factors of nodal involvement in T2 colorectal cancer. Dis Colon Rectum 2010;53:1393−99.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2014 Číslo 12
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Popliteal artery entrapment syndrome
- Complicated mesenteric ischaemia
- Transanal total mesorectal excision for rectal cancer – just a fashion trend?
- Predicting pN positivity in T3 rectal cancer